67 employees
BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.
2009
$18M
from 2 investors over 2 rounds
BioLamina AB raised $18M on September 12, 2023
Investors: Bure Equity AB and Lauxera Capital Partners